期刊文献+

多发性骨髓瘤周围神经病变诊疗中国专家共识(2015年) 被引量:41

原文传递
导出
摘要 周围神经病变(peripheralneuropathy,PN)在多发性骨髓瘤(multiplemyeloma,MM)患者中发生率较高。随着对MM诊治水平的提高,MM原发病及治疗相关PN发生率也逐渐增高,然而对于出现PN的患者如何更好地诊治,提高疗效及改善预后,目前国际上尚无统一的针对多发性骨髓瘤周围神经病变(MMPN)的诊疗指南可供参考。因此,我们在广泛征求国内有关专家意见的基础上,结合国际最新进展,达成以下共识。
出处 《中华内科杂志》 CAS CSCD 北大核心 2015年第9期821-824,共4页 Chinese Journal of Internal Medicine
  • 相关文献

参考文献24

  • 1Delforge M, Blade J, Dimopoulos MA, et al. Treatment-related peripheral neuropathy in multiple myeloma: the challenge continues[J]. Lancet Oncol, 2010, 11(11) :1086-1095.
  • 2Mohty B, E1-Cheikh J, Yakoub-Agha I, et al. Peripheral neuropathy and new treatments for multiple myeloma:baekground and practical recommendations [ J ]. Haematologiea, 2010, 95 (2) :311-319.
  • 3Sonnevcld P, Jongen JL. Dealing with neuropathy in plasma-cell dyscrasias [ J ]. Hematology Am Soc Hematol Educ Program, 2010, 2010:423-430.
  • 4Morawska M, Grzasko N, Kostyra M, et al. Therapy-related peripheral neuropathy in multiple myeloma patients [ J/OL ]. Hematol Oucol, 2014 [ 2015-06-09]. http ://onlinelibrary. wiley. com/doi/10. 1002/hon. 2149/epdf. [ published online ahead of print November 14, 2014].
  • 5Dimopnulos MA, Mateos MV, Richardson PG, et al. Risk factors for, and reversibility of, peripheral neuropathy associated with bortezomib-melphalan-prednisone in newly diagnosed patients with multiple myeloma:subanalysis of the phase 3 VISTA study [ J ]. Eur J Haematol, 2011, 86( 1 ) :23-31.
  • 6Richardson PG, Sonneveld P, Schuster MW, et al. Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase Ⅲ APEX trial in relapsed multiple myeloma: impact of a dose- modification guideline[J]. Br J Haematol, 2009, 144(6) :895- 903.
  • 7Hrusovsky I, Emmerich B, von Rohr A, et al. Bortezomib retreatment in relapsed multiple myeloma - results from a retrospective multieenter survey in Germany and Switzerland [ J ]. Oncology, 2010, 79(3-4):247-254.
  • 8Petrucci MT, Giraldo P, Corradini P, et al. A prospective, international phase 2 study of bortezomib retreatment in patients with relapsed multiple myeloma[ J]. Br J Haematol, 2013, 160 (5) :649-659.
  • 9Richardson PG, Xie W, Mitsiades C, et al. Single-agent bortezomib in previously untreated multiple myeloma: efficacy, characterization of peripheral neuropathy, and molecular correlations with response and neuropathy [ J ]. J Clin Oneol, 2009, 27(21 ) :3518-3525.
  • 10Richardson PG, Delforge M, Beksac M, et al. Management of treatment-emergent peripheral neuropathy in multiple myeloma [J]. Leukemia, 2012, 26(4) :595-608.

同被引文献295

引证文献41

二级引证文献117

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部